156 related articles for article (PubMed ID: 35961260)
1. Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity.
Perakakis N; Kokkinos A; Angelidi AM; Tsilingiris D; Gavrieli A; Yannakoulia M; Tentolouris N; Mantzoros CS
Clin Nutr; 2022 Sep; 41(9):1969-1976. PubMed ID: 35961260
[TBL] [Abstract][Full Text] [Related]
2. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial.
Perakakis N; Kalra B; Angelidi AM; Kumar A; Gavrieli A; Yannakoulia M; Mantzoros CS
Metabolism; 2022 Apr; 129():155157. PubMed ID: 35114286
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of all proglucagon-derived peptides are differentially regulated postprandially by obesity status and in response to high-fat meals vs. high-carbohydrate meals.
Stefanakis K; Kokkinos A; Simati S; Argyrakopoulou G; Konstantinidou SK; Kouvari M; Kumar A; Kalra B; Mantzoros CS
Clin Nutr; 2023 Aug; 42(8):1369-1378. PubMed ID: 37418844
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study.
Stefanakis K; Kokkinos A; Argyrakopoulou G; Konstantinidou SK; Simati S; Kouvari M; Kumar A; Kalra B; Kumar M; Bontozoglou N; Kyriakopoulou K; Mantzoros CS
Diabetes Obes Metab; 2023 Sep; 25(9):2561-2574. PubMed ID: 37246799
[TBL] [Abstract][Full Text] [Related]
5. Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial.
Kim SH; Abbasi F; Nachmanoff C; Stefanakis K; Kumar A; Kalra B; Savjani G; Mantzoros CS
Diabetes Obes Metab; 2021 Feb; 23(2):489-498. PubMed ID: 33140542
[TBL] [Abstract][Full Text] [Related]
6. Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1.
Rouillé Y; Kantengwa S; Irminger JC; Halban PA
J Biol Chem; 1997 Dec; 272(52):32810-6. PubMed ID: 9407057
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: Evidence from two independent trials.
Perakakis N; Kokkinos A; Peradze N; Tentolouris N; Ghaly W; Pilitsi E; Upadhyay J; Alexandrou A; Mantzoros CS
Metabolism; 2019 Dec; 101():153997. PubMed ID: 31672446
[TBL] [Abstract][Full Text] [Related]
8. Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study.
Alexiadou K; Cuenco J; Howard J; Wewer Albrechtsen NJ; Ilesanmi I; Kamocka A; Tharakan G; Behary P; Bech PR; Ahmed AR; Purkayastha S; Wheller R; Fleuret M; Holst JJ; Bloom SR; Khoo B; Tan TM
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32209584
[TBL] [Abstract][Full Text] [Related]
9. Enteroglucagon.
Holst JJ
Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
[TBL] [Abstract][Full Text] [Related]
10. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.
Polyzos SA; Perakakis N; Boutari C; Kountouras J; Ghaly W; Anastasilakis AD; Karagiannis A; Mantzoros CS
J Clin Endocrinol Metab; 2020 Mar; 105(3):e390-400. PubMed ID: 31690932
[TBL] [Abstract][Full Text] [Related]
11. Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion.
Dhanvantari S; Brubaker PL
Endocrinology; 1998 Apr; 139(4):1630-7. PubMed ID: 9528943
[TBL] [Abstract][Full Text] [Related]
12. Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
Manell H; Staaf J; Manukyan L; Kristinsson H; Cen J; Stenlid R; Ciba I; Forslund A; Bergsten P
J Clin Endocrinol Metab; 2016 Mar; 101(3):1181-9. PubMed ID: 26745255
[TBL] [Abstract][Full Text] [Related]
13. Fasting levels of glicentin are higher in Roux-en-Y gastric bypass patients exhibiting postprandial hypoglycemia during a meal test.
Poitou C; Bouaziz-Amar E; Genser L; Oppert JM; Lacorte JM; Le Beyec J
Surg Obes Relat Dis; 2018 Jul; 14(7):929-935. PubMed ID: 29703503
[TBL] [Abstract][Full Text] [Related]
14. Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry after a Meal Tolerance Test.
Lee AY; Chappell DL; Bak MJ; Judo M; Liang L; Churakova T; Ayanoglu G; Castro-Perez J; Zhou H; Previs S; Souza SC; Lassman ME; Laterza OF
Clin Chem; 2016 Jan; 62(1):227-35. PubMed ID: 26430077
[TBL] [Abstract][Full Text] [Related]
15. Fasting oxyntomodulin, glicentin, and gastric inhibitory polypeptide levels are associated with activation of reward- and attention-related brain centres in response to visual food cues in adults with obesity: A cross-sectional functional MRI study.
Perakakis N; Farr OM; Mantzoros CS
Diabetes Obes Metab; 2021 May; 23(5):1202-1207. PubMed ID: 33417264
[TBL] [Abstract][Full Text] [Related]
16. Proglucagon processing in islet and intestinal cell lines.
Tucker JD; Dhanvantari S; Brubaker PL
Regul Pept; 1996 Apr; 62(1):29-35. PubMed ID: 8738879
[TBL] [Abstract][Full Text] [Related]
17. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
18. Central pre-proglucagon derived peptides: opportunities for treatment of obesity.
Larsen PJ; Vrang N; Tang-Christensen M
Curr Pharm Des; 2003; 9(17):1373-82. PubMed ID: 12769729
[TBL] [Abstract][Full Text] [Related]
19. Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats.
Fischer KD; Dhanvantari S; Drucker DJ; Brubaker PL
Am J Physiol; 1997 Oct; 273(4):E815-20. PubMed ID: 9357813
[TBL] [Abstract][Full Text] [Related]
20. Role of prohormone convertases in the tissue-specific processing of proglucagon.
Dhanvantari S; Seidah NG; Brubaker PL
Mol Endocrinol; 1996 Apr; 10(4):342-55. PubMed ID: 8721980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
